Creative Medical Technology (CELZ) Competitors $1.99 -0.08 (-3.86%) Closing price 05/1/2025 03:59 PM EasternExtended Trading$2.13 +0.15 (+7.29%) As of 08:21 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CELZ vs. CLRB, ABP, NRSN, IPA, MEIP, ME, CLDI, ABVC, SYBX, and TXMDShould you be buying Creative Medical Technology stock or one of its competitors? The main competitors of Creative Medical Technology include Cellectar Biosciences (CLRB), Abpro (ABP), NeuroSense Therapeutics (NRSN), ImmunoPrecise Antibodies (IPA), MEI Pharma (MEIP), 23andMe (ME), Calidi Biotherapeutics (CLDI), ABVC BioPharma (ABVC), Synlogic (SYBX), and TherapeuticsMD (TXMD). These companies are all part of the "pharmaceutical products" industry. Creative Medical Technology vs. Cellectar Biosciences Abpro NeuroSense Therapeutics ImmunoPrecise Antibodies MEI Pharma 23andMe Calidi Biotherapeutics ABVC BioPharma Synlogic TherapeuticsMD Cellectar Biosciences (NASDAQ:CLRB) and Creative Medical Technology (NASDAQ:CELZ) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their community ranking, valuation, dividends, earnings, media sentiment, analyst recommendations, profitability, institutional ownership and risk. Which has preferable valuation and earnings, CLRB or CELZ? Creative Medical Technology has higher revenue and earnings than Cellectar Biosciences. Creative Medical Technology is trading at a lower price-to-earnings ratio than Cellectar Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCellectar BiosciencesN/AN/A-$42.77M-$1.33-0.20Creative Medical Technology$11K793.29-$5.29M-$3.71-0.54 Is CLRB or CELZ more profitable? Cellectar Biosciences' return on equity of 0.00% beat Creative Medical Technology's return on equity.Company Net Margins Return on Equity Return on Assets Cellectar BiosciencesN/A N/A -191.22% Creative Medical Technology N/A -63.05%-60.42% Do insiders & institutionals believe in CLRB or CELZ? 16.4% of Cellectar Biosciences shares are held by institutional investors. Comparatively, 1.4% of Creative Medical Technology shares are held by institutional investors. 3.7% of Cellectar Biosciences shares are held by company insiders. Comparatively, 2.8% of Creative Medical Technology shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Do analysts recommend CLRB or CELZ? Cellectar Biosciences presently has a consensus target price of $12.50, indicating a potential upside of 4,631.26%. Given Cellectar Biosciences' stronger consensus rating and higher probable upside, analysts clearly believe Cellectar Biosciences is more favorable than Creative Medical Technology.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cellectar Biosciences 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50Creative Medical Technology 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has more volatility & risk, CLRB or CELZ? Cellectar Biosciences has a beta of 0.67, indicating that its share price is 33% less volatile than the S&P 500. Comparatively, Creative Medical Technology has a beta of 2, indicating that its share price is 100% more volatile than the S&P 500. Does the MarketBeat Community favor CLRB or CELZ? Cellectar Biosciences received 172 more outperform votes than Creative Medical Technology when rated by MarketBeat users. However, 68.93% of users gave Creative Medical Technology an outperform vote while only 53.76% of users gave Cellectar Biosciences an outperform vote. CompanyUnderperformOutperformCellectar BiosciencesOutperform Votes24353.76% Underperform Votes20946.24% Creative Medical TechnologyOutperform Votes7168.93% Underperform Votes3231.07% Does the media prefer CLRB or CELZ? In the previous week, Cellectar Biosciences had 1 more articles in the media than Creative Medical Technology. MarketBeat recorded 3 mentions for Cellectar Biosciences and 2 mentions for Creative Medical Technology. Creative Medical Technology's average media sentiment score of 1.61 beat Cellectar Biosciences' score of 0.47 indicating that Creative Medical Technology is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cellectar Biosciences 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Creative Medical Technology 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive SummaryCellectar Biosciences beats Creative Medical Technology on 10 of the 16 factors compared between the two stocks. Get Creative Medical Technology News Delivered to You Automatically Sign up to receive the latest news and ratings for CELZ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CELZ vs. The Competition Export to ExcelMetricCreative Medical TechnologyBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.73M$2.95B$5.54B$7.93BDividend YieldN/A1.89%5.09%4.23%P/E Ratio-0.5230.0722.5318.54Price / Sales793.29494.82399.57103.29Price / CashN/A168.6838.1834.62Price / Book0.273.176.774.25Net Income-$5.29M-$72.35M$3.22B$248.18M7 Day Performance1.02%2.14%1.11%0.91%1 Month Performance-7.01%5.67%2.50%2.58%1 Year Performance-56.26%-23.57%15.76%4.02% Creative Medical Technology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CELZCreative Medical Technology1.1945 of 5 stars$1.99-3.9%N/A-56.5%$8.73M$11,000.00-0.525Upcoming EarningsPositive NewsCLRBCellectar Biosciences1.7408 of 5 stars$0.30+4.3%$12.50+4,028.1%-91.6%$13.95MN/A-0.1810Gap UpABPAbproN/A$0.27+15.6%$4.00+1,398.1%N/A$13.84M$183,000.000.0015Gap UpHigh Trading VolumeNRSNNeuroSense Therapeutics1.1253 of 5 stars$1.01+1.0%N/A-17.6%$13.80MN/A-1.5810Short Interest ↓Negative NewsIPAImmunoPrecise Antibodies2.8528 of 5 stars$0.44+6.9%$4.00+819.5%-62.7%$13.51M$24.00M-0.5680Short Interest ↓Gap UpMEIPMEI Pharma1.6023 of 5 stars$2.02+5.8%N/A-33.0%$13.46M$65.30M-0.35100Upcoming EarningsAnalyst ForecastShort Interest ↑Gap UpME23andMeN/A$0.50-35.3%N/A-95.0%$13.36M$208.78M-0.03770Gap DownHigh Trading VolumeCLDICalidi Biotherapeutics2.002 of 5 stars$0.46+5.0%$15.00+3,146.8%N/A$13.15M$50,000.000.0038Gap DownABVCABVC BioPharma0.7331 of 5 stars$0.83-4.7%N/A-8.8%$13.12M$509,788.00-0.9730Earnings ReportSYBXSynlogic2.4429 of 5 stars$1.12+5.3%N/A-39.2%$13.05M$8,000.00-0.2780Short Interest ↓TXMDTherapeuticsMD1.766 of 5 stars$1.11+11.4%N/A-26.1%$12.85M$1.76M0.00420Upcoming EarningsAnalyst Forecast Related Companies and Tools Related Companies Cellectar Biosciences Alternatives Abpro Alternatives NeuroSense Therapeutics Alternatives ImmunoPrecise Antibodies Alternatives MEI Pharma Alternatives 23andMe Alternatives Calidi Biotherapeutics Alternatives ABVC BioPharma Alternatives Synlogic Alternatives TherapeuticsMD Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CELZ) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Creative Medical Technology Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Creative Medical Technology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
